Chembio Diagnostics, Inc. (CEMI.PK) reported first-quarter net income of $0.4 million or $0.01 per share, compared to a net loss of $0.1 million or breakeven per share last year.
Total revenues for the quarter rose sharply to $6.7 million from $3.6 million a year ago.
Lawrence Siebert, the chief executive officer of the company, said "2012 has gotten off to a very strong start with record product sales more than doubling compared with the prior year. These gains were led by increased purchase orders from the Oswaldo Cruz Foundation, our license and technology partner in Brazil, and from continued strong demand for our rapid HIV tests in the U.S."
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.